BioSurface Technology (IPO 1993, Acquired by Genzyme in 1995), Genetics Institute (IPO 1986, Acquired by American Home Products in 1997), Millipore (IPO 1987), Teradyne (IPO 1970), Worthington Biochemical (IPO 1971, Acquired by Millipore in 1975)
Venture Capital Pioneer and Greylock Founder
Daniel S. Gregory co-founded Greylock Partners in Boston in 1965, and served as the second managing partner, a general partner, a special limited partner, and Chairman of the firm’s Board of Directors. Over a period of 45 years, the venture firm has raised a series of thirteen partnerships, with committed capital in excess $3.0 billion, and has helped finance and build over 300 developing technology companies. Having worked for several years with John P. Chase, an investment management firm, Dan Gregory joined with American, Research & Development veteran, Bill Elfers, to create Greylock, one of the first Boston based venture capital limited partnerships. Over the course of his 40 plus years in venture capital, Dan led investments in companies such as NEBS, Teradyne, Genetics Institute, Worthington Biochemical, Environmental Research & Technology, and Massachusetts Computer Corporation. Respected as a leader by his peers, Dan Gregory was elected to serve on the National Venture Capital (NVCA) board from 1978 to 1985, to be President from 1983 to 1984, and to be Chairman from 1984 to 1985. In January, 1991, Dan withdrew from Greylock to serve under newly elected Massachusetts Governor William Weld as the Secretary of Economic Affairs. He returned to the firm in May, 1992. In October, 2003, Dan, along with his founding partner and early general partners, received the Harvard Business School Award for Alumni Achievement.